Champions Oncology (CSBR) Other Accumulated Expenses (2021 - 2026)

Champions Oncology's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $78000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 49.35% year-over-year to $78000.0; the TTM figure through Jan 2026 stood at $78000.0 (down 49.35% YoY), while the FY2025 annual figure was $135000.0, down 10.0% from the prior year.
• Other Accumulated Expenses was $78000.0 for Q1 2026 at Champions Oncology, down from $97000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $154000.0 in Q1 2025 to a low of $15000.0 in Q1 2022.
• Historically, Other Accumulated Expenses has averaged $125647.1 across 5 years, with a median of $144000.0 in 2023.
• The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses surged 860.0% in 2023, then tumbled 49.35% in 2026.
• A 5-year view of Other Accumulated Expenses shows it stood at $143000.0 in 2022, then gained by 3.5% to $148000.0 in 2023, then grew by 2.03% to $151000.0 in 2024, then plunged by 35.76% to $97000.0 in 2025, then dropped by 19.59% to $78000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $78000.0 (Q1 2026), $97000.0 (Q4 2025), and $116000.0 (Q3 2025), per Business Quant data.